OSLO,
Norway, Dec. 21, 2023 /PRNewswire/ -- Navamedic
ASA (OSE: NAVA), a Nordic pharma company and reliable
provider of high-quality products to hospitals and pharmacies,
today announces it has renewed its contract with Vitaflo
International Limited (Vitaflo International), granting Navamedic
the exclusive rights to market and distribute Vitaflo
International's medical nutrition products across the Nordic region
for an additional five years.
This agreement follows a longstanding partnership between
Navamedic and Vitaflo International, dating back to 2005. Vitaflo
International's medical nutrition products make up Navamedic's IEM
(inborn error of metabolism) products and are part of the Hospital
segment.
"We are thrilled to have renewed the contract with Vitaflo
International, which underpins the strength of Navamedic's
marketing and distribution channels in the Nordics. The medical
nutrition product portfolio represents one of Navamedic's key
product offerings to our customers in the Nordics, and we look
forward to continuing our collaboration and partnership with
Vitaflo International," commented Kathrine
Gamborg Andreassen, CEO of Navamedic.
For further information, please contact:
Kathrine Gamborg Andreassen, CEO,
Navamedic
Mobile: +47 951 78 680
E-mail: kathrine@navamedic.com
Lars Hjarrand, CFO, Navamedic
Mobile: +47 917 62 842
E-mail: lars.hjarrand@navamedic.com
About Navamedic
Navamedic ASA is a full-service provider of high-quality
healthcare products to hospitals and pharmacies. Navamedic meets
the specific medical needs of patients and consumers by leveraging
its highly scalable market access platform, leading category
competence and local knowledge. Navamedic is present in all the
Nordic countries, the Baltics and Benelux, with sales
representation in the UK and Greece. Navamedic is headquartered in
Oslo, Norway, and listed on the
Oslo Stock Exchange (ticker: NAVA). For more information, please
visit Navamedic.com.
View original
content:https://www.prnewswire.co.uk/news-releases/navamedic-asa-renewed-contract-signed-with-vitaflo-international-limited-302021149.html